Lower-dose ketorolac for pain in the ICU
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether a lower dose of the pain medicine ketorolac can safely control pain for people in the intensive care unit (ICU). If you are in the ICU and have pain, this study might help find a better way to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently admitted to an intensive care unit (ICU).
- You have pain that is more than mild, whether reported by you or noted by staff.
- You are expected to stay in the ICU for at least 48 hours.
- You are not pregnant or breastfeeding.
- You do not have serious kidney, stomach, heart, liver, or bleeding problems, and you are not allergic to NSAID pain relievers like ibuprofen or ketorolac.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a low dose of a non-steroidal anti-inflammatory drug (NSAID) called ketorolac for a short time after orthopedic surgery can reduce the need for strong painkillers like opioids. It is for people who have broken bones that need surgery with metal plates, screws, or rods.
This trial looks at whether a ketorolac pain medicine given directly to the leg during surgery can reduce pain after lower-limb orthopedic operations. It may help people who are having one leg operated on with spinal anesthesia and a tourniquet, but it has several safety limits.
This trial tests if a non-steroidal anti-inflammatory drug (NSAID) called ketorolac can help reduce pain after lower back fusion surgery. It is for people who are having elective surgery to fuse one or two bones in their lower back.
This study tests whether ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), helps manage pain after hip surgery. It may offer an opioid-sparing option for patients with femoroacetabular impingement (FAI).
This study compares two common pain relievers—ketorolac and morphine—given through an IV to children with acute abdominal pain. It aims to find which works better and has fewer side effects for this condition.
This trial tests a pain medicine called ketorolac (an NSAID) to see if it helps children with sickle cell disease who come to the emergency room or clinic with sudden, severe pain. If your child has sickle cell disease and is having an acute pain crisis, this study may be an option.
Hear when a new Pain Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.